The Sanger Institute Board of Management

The Sanger Institute's Board of Management (BoM) includes the Heads of the five Science Programmes, the Chief Operating Officer, the Director of Scientific Operations and the Head of Finance. The BoM is responsible for advising and supporting the Director in his management responsibilities. Specifically it ensures that the Institute’s science is delivered according to its research plans through effective leadership, management and oversight.  The BoM has delegated authority from the GRL Executive and its members are as below: 

Mike Stratton - Director

Mike is Director of the Sanger Institute and Chair of the Board of Management.

Mike's Director Page

Matt Hurles - Head of Human Genetics Programme

Matt's Profile

Human Genetics Programme

Peter Campbell - Head of Cancer, Ageing and Somatic Mutation Programme

Peter's profile

Cancer, Ageing and Somatic Mutation Programme

Martin Dougherty - Chief Operating Officer

Martin's profile

Genny Kiff - Interim Chief Financial Officer

Genny's profile

Dominic Kwiatkowski - Head of Malaria Programme

Dominic's profile

Malaria Programme

Emma Millican - Director of Scientific Operations

Emma's profile

Scientific Operations

Julian Parkhill - Head of Infection Genomics Programme

Julian's Profile

Infection Genomics Programme

Sarah Teichmann - Head of Cellular Genetics

Sarah's profile

Cellular Genetics Programme